Homodimeric protein constructs

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 11479605
APP PUB NO 20200239568A1
SERIAL NO

16784778

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to novel recombinant fusion proteins, such as human antibody-based molecules called Vaccibodies, which are able to trigger both a T cell- and B cell immune response. The present invention also relates to a method of treating a cancer or an infectious disease by means of these specific fusion proteins.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • NYKODE THERAPEUTICS ASA

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Bogen, Bjarne Snaroya, NO 21 59
Fredriksen, Agnete Brunsvik Raelingen, NO 15 5
Ruffini, Pier Adelchi Milan, IT 4 4

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Apr 25, 2026
7.5 Year Payment $3600.00 $1800.00 $900.00 Apr 25, 2030
11.5 Year Payment $7400.00 $3700.00 $1850.00 Apr 25, 2034
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00